Krystal Biotech, Inc. KRYS
296.89 USD -8.35 (-2.73%)
As ofNov 16, 2026, 2:55 PM EST
296.43 Day range 306.44
202.99 52-week range 382.54
- YTD
- +20.42%
- 1 year
- +44.01%
News
defenseworld.net Revolution Medicines (NASDAQ:RVMD) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Survey Krystal Biotech (NASDAQ: KRYS - Get Free Report) and Revolution Medicines (NASDAQ: RVMD - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two…benzinga.com Citigroup Maintains Buy on Krystal Biotech, Lowers Price Target to $412 Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and lowers the price target from $416 to $412.
benzinga.com TD Cowen Maintains Buy on Krystal Biotech, Lowers Price Target to $380 TD Cowen analyst Ritu Baral maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and lowers the price target from $403 to $380.
benzinga.com RBC Capital Maintains Outperform on Krystal Biotech, Lowers Price Target to $375 RBC Capital analyst Lisa Walter maintains Krystal Biotech (NASDAQ:KRYS) with a Outperform and lowers the price target from $400 to $375.
benzinga.com Krystal Biotech Analyst Says Stock Weakness 'Overblown' Krystal Biotech beats Q3 earnings, but trial delays send shares lower. Analysts call the market drop overblown and highlight a potential buying opportunity.
benzinga.com Krystal Biotech Q3 2026 Earnings Call Transcript Krystal Biotech (NASDAQ:KRYS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…benzinga.com Krystal Biotech Q3 EPS $2.05 Beats $1.77 Estimate, Sales $127.341M Beat $126.079M Estimate Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $2.05 per share which beat the analyst consensus estimate of $1.77 by 15.82 percent. This is a 22.93 percent decrease over earnings of…
benzinga.com Apple, Palantir On Deck Monday As AI Demand, iPhone Growth Face Test Apple headlines Monday’s reports, with investors looking for continued iPhone momentum and evidence that its artificial-intelligence push can support the company’s next leg of growth. Marriott…
benzinga.com Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 31.65% on an annualized basis producing an average annual return of 42.52%. Currently, Krystal Biotech has a market…
